Brii Biosciences (2137.HK) Earnings Analysis
Brii Biosciences (2137.HK) next reports earnings on 2026-08-20, consensus EPS -0.10991 HKD. Last quarter (2026-03-19) it missed with EPS -0.10991 HKD vs -0.06677 HKD est (-64.6%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -2.80.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2137.HK next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | -0.10991 HKD |
| Revenue estimate | 0.02B |
2137.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-19 | -0.10991 HKD | -0.06677 HKD | -64.6% | Miss |
| 2025-08-21 | -0.20464 HKD | -0.29587 HKD | +30.8% | Beat |
| 2025-03-21 | -0.33136 HKD | -0.2448 HKD | -35.4% | Miss |
| 2024-08-19 | -0.41286 HKD | -0.36531 HKD | -13% | Miss |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
2137.HK valuation and analyst view
| Trailing P/E | -2.80 |
|---|---|
| Trailing EPS | -0.30182 HKD |
| Price / book | 0.25 |
| Dividend yield | 0.00% |
| Market cap | 0.72B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Brii Biosciences (2137.HK)'s next earnings date?
Brii Biosciences is next scheduled to report on 2026-08-20, with a consensus EPS estimate of -0.10991 HKD and revenue estimate of 0.02B.
Did 2137.HK beat earnings last quarter?
In its 2026-03-19 report, 2137.HK posted EPS of -0.10991 HKD versus a -0.06677 HKD estimate — a miss of 64.6%.
What is 2137.HK's earnings track record?
Over the last 4 reported quarters with consensus data, 2137.HK beat estimates 1 times (25%).
What is 2137.HK's current P/E ratio and EPS?
2137.HK trades at a trailing P/E of -2.80 on trailing EPS of -0.301823844198935 HKD.
What do analysts rate 2137.HK?
2137.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.